[發展經濟學研討會]Time Enough for Safety: Comment on “The Complications of Controlling Agency Time Discretion: FDA Review Deadlines and Postmarket Drug Safety”
發文時間：2015-03-12

發展經濟學研討會

【總第28期】 



【時間】 3月18日，星期三， 12:00—14:00 
【地點】：明德主樓734會議室
【主講人】： ANDREAS M. SCHICK 
【主題】： Time Enough for Safety: Comment on “The Complications of Controlling Agency Time Discretion: FDA Review Deadlines and Postmarket Drug Safety”
【摘要】：
 Carpenter, Chattopadhyay, Moffitt, and Nall (2012) present results that suggest that time constraints on new-drug reviews are positively associated with post-market safety outcomes. However, their analysis omits obvious confounding variables, and their data set contains several clear errors. In regressions using a clean data set and plausible confounding variables, we find that the relationship between time constraints on new-drug reviews and post-market safety events is neither robust nor statistically significant.


【演講人簡要簡介】
 ANDREAS M. SCHICK是美國食品與藥品監管局資深經濟學家，2011年博士畢業于俄亥俄州立大學，主要研究健康經濟學、健康政策、經濟史和勞動經濟學。SCHICK博士有大量實際工作經驗，并在如 Journal of Human Capital等雜志發表若干論文。


中國人民大學經濟學院 2015年3月12日